ResApp is a biotech company that commercialised technology to diagnose respiratory illnesses based on an audio recording of a patient’s cough on their phone. After proving immensely useful for diagnosing COVID-19 during the height of pandemic, Pfizer acquired the company for $180 million.Throughout the episode, Tony discusses the path of listing on the ASX early-on and how that provided the initial capital needed for the company to succeed. Coming from a research background, Tony also talks about how his experience as a scholar and background in engineering contributes to being an effective CEO.If you enjoy this episode, feel free to share with family and friends and leave a 5 star review.Share the episode: https://thedionguagliardopodcast.buzzsprout.com/shareMore on us! Dion's Newsletter: http://eepurl.com/hHg1ff Our social media: https://linktr.ee/FortressFinancial Fortress Family Office: https://www.fortressfamilyoffice.com/ Contact us: [email protected]

Ver todos los episodios